Advertisement
Screener

ChemoCentryx, Inc. Operating Lease, Payments

ChemoCentryx, Inc. Operating Lease, Payments

ChemoCentryx, Inc. reported Operating Lease, Payments of $4.00 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:OperatingLeasePayments · last filed 2022-08-08

  • ChemoCentryx, Inc. operating lease, payments for the quarter ending 2022-06-30 was $2.00M, a 53.85% increase year-over-year.
  • ChemoCentryx, Inc. operating lease, payments for the quarter ending 2022-03-31 was $2.00M, a 185.71% increase year-over-year.
  • ChemoCentryx, Inc. operating lease, payments for the quarter ending 2021-12-31 was $2.10M, a 320.00% increase year-over-year.
  • ChemoCentryx, Inc. operating lease, payments for the quarter ending 2021-09-30 was $1.10M, a 168.29% increase year-over-year.
  • ChemoCentryx, Inc. operating lease, payments for fiscal 2021 was $5.20M, a 205.88% increase from fiscal 2020.
  • ChemoCentryx, Inc. operating lease, payments for fiscal 2020 was $1.70M, a 30.77% increase from fiscal 2019.
  • ChemoCentryx, Inc. operating lease, payments for fiscal 2019 was $1.30M.
Period endOperating Lease, Payments 3 monthOperating Lease, Payments 6 monthOperating Lease, Payments 9 monthOperating Lease, Payments 9 month as first filedOperating Lease, Payments 12 month
2022-06-30$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$4.00M
10-Q · filed 2022-08-08
$6.10M
derived: sum of 3 quarters · filed 2022-08-08
$7.20M
derived: sum of 4 quarters · filed 2022-08-08
2022-03-31$2.00M
10-Q · filed 2022-05-10
$4.10M
derived: sum of 2 quarters · filed 2022-05-10
$5.20M
derived: sum of 3 quarters · filed 2022-05-10
$6.50M
derived: sum of 4 quarters · filed 2022-08-08
2021-12-31$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$3.20M
derived: sum of 2 quarters · filed 2022-03-01
$4.50M
derived: sum of 3 quarters · filed 2022-08-08
$5.20M
10-K · filed 2022-03-01
2021-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$2.40M
derived: sum of 2 quarters · filed 2022-08-08
$3.10M
10-Q · filed 2021-11-09
$3.60M
derived: sum of 4 quarters · filed 2022-08-08
2021-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$2.00M
10-Q · filed 2022-08-08
$2.50M
derived: sum of 3 quarters · filed 2022-08-08
$2.91M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$700.00K
10-Q · filed 2022-05-10
$1.20M
derived: sum of 2 quarters · filed 2022-05-10
$1.61M
derived: sum of 3 quarters · filed 2022-05-10
$2.02M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$910.00K
derived: sum of 2 quarters · filed 2022-03-01
$1.32M
derived: sum of 3 quarters · filed 2022-03-01
$1.70M
10-K · filed 2022-03-01
2020-09-30$410.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$825.00K
derived: sum of 2 quarters · filed 2020-11-09
$1.20M
10-Q · filed 2020-11-09
$1.60M
derived: sum of 4 quarters · filed 2021-03-01
2020-06-30$415.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$790.00K
10-Q · filed 2020-08-10
$1.19M
derived: sum of 3 quarters · filed 2021-03-01
$1.52M
derived: sum of 4 quarters · filed 2021-03-01
2020-03-31$375.00K
10-Q · filed 2020-05-11
$775.00K
derived: sum of 2 quarters · filed 2021-03-01
$1.11M
derived: sum of 3 quarters · filed 2021-03-01
$1.44M
derived: sum of 4 quarters · filed 2021-03-01
2019-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$735.00K
derived: sum of 2 quarters · filed 2021-03-01
$1.06M
derived: sum of 3 quarters · filed 2021-03-01
$1.30M
10-K · filed 2021-03-01
2019-09-30$335.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$664.00K
derived: sum of 2 quarters · filed 2020-11-09
$900.00K
10-Q · filed 2020-11-09
$940.00K
10-Q · filed 2019-11-04
2019-06-30$329.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$565.00K
10-Q · filed 2020-08-10
2019-03-31$236.00K
10-Q · filed 2019-05-06